Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Other Accumulated Expenses (2025 - 2026)

Updated

Odyssey Therapeutics (ODTX) recorded Other Accumulated Expenses of $839,000 in Q3 2026, up 70.5% from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Other Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025, Odyssey Therapeutics reported Other Accumulated Expenses of $374,000.

  • Per Business Quant, the preceding three quarters came in at $492,000 (Q2 2026), $399,000 (Q1 2026) and $374,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 839,000.00
Jun 30, 2026 492,000.00
Mar 31, 2026 399,000.00
Dec 31, 2025 374,000.00
API Access

Odyssey Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ODTX&period=max&api_key=YOUR_API_KEY